SARS-CoV-2

Yuka Otsuka1, Eunjung Kim2, Austin Krueger2

  • 1The Herbert Wertheim UF Scripps Institute for Biomedical Innovation & Technology, Department of Molecular Medicine, Midwest AViDD HTS Core B, Jupiter, FL 33458, United States.

概括

研究人员选了超过65万种化合物,以寻找SARS-CoV-2 nsP13螺旋酶的抑制剂. 这种高通量查确定了674种潜在的抗病毒化合物,目标是关键的SARS-CoV-2蛋白质.